Tectonic Therapeutic, Inc.

TECX Healthcare Biotechnology

EPS
−10.3%
Free cash flow
−46.7%
Total debt
−94.0%

Quarter to June 2026, against a year earlier

20.62 1.20 +6.18%
Market cap
$379.7M
P/E
0.0×
Fwd P/E
—
Dividend yield
—
F-score
n/a
Altman Z
n/a
Beneish M
n/a
Dividend safety
n/a
Older periods Sep '25 Dec '25 Mar '26 Jun '26
Current Ratio

+8 more quarters

29.15 26.63 18.51 22.29
Net Debt/EBITDA
12.48 12.01 8.77 9.49
Debt/Equity
0.00 0.00 0.00 0.00
Free Cash Flow per Share
(0.96) (0.79) (0.98) (1.13)
Book value per Share
14.30 13.72 12.28 11.80
Free Cash Flow
(17.98) (14.46) (18.43) (21.51)
Other line items

Show all line items

Columns are period end dates